Reduced Inflammatory Activity in Atherosclerotic Plaques after Peptide Receptor-Targeted Radionuclide Therapy Detected by [68Ga]Ga-DOTATOC PET

被引：0
|
作者：
Kosmala, Aleksander
Weich, Alexander
Serfling, Sebastian
Schlotelburg, Wiebke
Michalski, Kerstin
Meining, Alexander
Higuchi, Takahiro
Buck, Andreas
Werner, Rudolf
Hartrampf, Philipp
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242046
引用
收藏
页数：3
相关论文
共 50 条
  • [41] 68Ga-DOTATATE PET/CT for the early prediction of response to peptide receptor radionuclide therapy in patients with well differentiated neuroendocrine tumours
    Haug, Alexander
    Auernhammer, Christoph
    Waengler, Bjoern
    Schmidt, Gerwin
    Cumming, Paul
    Bartenstein, Peter
    Hacker, Marcus
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [42] Management of Neuroendocrine Tumors of the Rectum (rNET) Using Ga-68 Somatostatin Receptor PET/CT (SR-PET/CT) and Peptide Receptor Radionuclide Therapy (PRRT)
    Prasad, V
    Kaemmerer, D.
    Hommann, M.
    Hoersch, D.
    Zachert, C.
    Baum, R. P.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 132 - 132
  • [43] Prospective phase II trial of [68Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy
    Azam, Aleena
    Kurbegovic, Sorel
    Carlsen, Esben Andreas
    Andersen, Thomas Lund
    Larsen, Vibeke Andre
    Law, Ian
    Skjoth-Rasmussen, Jane
    Kjaer, Andreas
    EJNMMI RESEARCH, 2024, 14 (01):
  • [44] Multimodal Imaging for Early Functional Response Assessment of 90Y-/177Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and 68Ga-DOTATOC-PET/CT
    Wulfert, Sarah
    Kratochwil, Clemens
    Choyke, Peter L.
    Afshar-Oromieh, Ali
    Mier, Walter
    Kauczor, Hans-Ulrich
    Schenk, Jens-Peter
    Haberkorn, Uwe
    Giesel, Frederik L.
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (04) : 586 - 594
  • [45] Multimodal Imaging for Early Functional Response Assessment of 90Y-/177Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and 68Ga-DOTATOC-PET/CT
    Sarah Wulfert
    Clemens Kratochwil
    Peter L. Choyke
    Ali Afshar-Oromieh
    Walter Mier
    Hans-Ulrich Kauczor
    Jens-Peter Schenk
    Uwe Haberkorn
    Frederik L. Giesel
    Molecular Imaging and Biology, 2014, 16 : 586 - 594
  • [46] Development of a 68Ga/177Lu-labeled universal bombesin peptide ligand for the diagnosis and targeted therapy of bombesin receptor-expressing tumors.
    Okarvi, S.
    AlJammaz, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S274 - S275
  • [47] A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy
    Ballal, Sanjana
    Yadav, Madhav Prasad
    Kramer, Vasko
    Moon, Euy Sung
    Roesch, Frank
    Tripathi, Madhav
    Mallick, Soumyaranjan
    ArunRaj, Sreedharan Thankarajan
    Bal, Chandrasekhar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (03) : 942 - 944
  • [48] Comparison of renal uptake of 68Ga-DOTANOC PET/CT and estimated glomerular filtration rate before and after peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumours
    Kaewput, Chalermrat
    Vinjamuri, Sobhan
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (12) : 1325 - 1332
  • [49] A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy
    Sanjana Ballal
    Madhav Prasad Yadav
    Vasko Kramer
    Euy Sung Moon
    Frank Roesch
    Madhav Tripathi
    Soumyaranjan Mallick
    Sreedharan Thankarajan ArunRaj
    Chandrasekhar Bal
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 942 - 944
  • [50] Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer
    Michalski, Kerstin
    Stoykow, Christian
    Bronsert, Peter
    Juhasz-Boess, Ingolf
    Meyer, Philipp T.
    Ruf, Juri
    Erbes, Thalia
    Asberger, Jasmin
    NUCLEAR MEDICINE AND BIOLOGY, 2020, 86-87 : 37 - 43
12345